China Pharma Holdings, Inc.

CPHIAMEX • USD
0.66 USD
↗ 0.00 (0.61%)AT CLOSE (03:59 PM EDT)
0.66
↘ 0.00 (0.29%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
0.66
↘ 0.00 (0.29%)
🔴Market: CLOSED

China Pharma Holdings, Inc. (CPHI) trades at $0.66 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, CPHI trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Oct 2, 2026.

Open?$0.64
High?$0.66
Low?$0.64
Prev. Close?$0.65
Volume?119.3K
Avg. Volume?231.0K
VWAP?$0.65
Rel. Volume?0.52x
Bid / Ask
Bid?$0.64 × 600
Ask?$0.68 × 200
Spread?$0.04
Midpoint?$0.66
Valuation & Ratios
Market Cap?28.4M
Shares Out?43.0M
Float?2.0M
Float %?4.8%
P/E Ratio?N/A
P/B Ratio?0.78
EPS?-$0.10
Dividend?0.00%
Ex-Dividend?N/A
RelatedUTZ
News
Profile
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
Employees
221
Market Cap
28.3M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2002-04-14
Address
2ND FLOOR, NO. 17, JINPAN ROAD
HAINAN PROVINCE, F4 570216
Phone: 8689866811730
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
3
Momentum?
17
Short Sent.?
71
Piotroski F-Score?2/9Weak
Altman Z-Score?0.05Distress
Confidence?51%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?9.31%Elevated
Short Interest?182.6K
Days to Cover?1.9
Free Float2.0M
Avg Daily Volume95.4K
Settlement Date2026-09-15
Financial Health
Current Ratio?0.26Weak
Quick Ratio?0.08Weak
Cash Ratio?0.04Low
Debt/Equity?0.10Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.78CHEAP▾
P/S?
Peers
50
S&P
16
7.25HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
-22.0CHEAP▾
EV/Sales?
Peers
50
S&P
16
8.10HIGH▾
Returns & Efficiency
ROE?
S&P
9
-12.4%WEAK▾
ROA?
S&P
3
-10.0%WEAK▾
Cash Flow & Enterprise
FCF?$-174182
Enterprise Value?$31.7M
Fundamentals ratios updated end of day